David Pennington, vice president of sales for Tissue Regenix BioSurgery, stated, “We chose ARMS Medical as our exclusive distributor because of their strong relationships with Key Opinion Leaders in the urogyn space. Additionally, they are known for bringing innovation to women’s pelvic health solutions. ARMS Medical has helped us extend the use of DermaPure into pelvic floor surgery which could open the opportunity for a more novel approach compared to existing technologies. Together, we are providing education and onboarding for surgeons with the goal of improving patient outcomes and satisfaction.”

Rob Greer, Founder of ARMS Medical, commented “Our strong partnership with Tissue Regenix is advancing the treatment options for pelvic floor surgery. We believe DermaPure allograft is the optimal solution for repairing pelvic organ prolapse and other conditions, and it is a key component of our suite of innovative products. This distribution agreement will empower ARMS Medical to expand adoption of DermaPure by hospitals and surgeons for the benefit of women.”

The company reports DermaPure is a next-generation decellularized dermal allograft processed with patented dCELL® technology. The dCELL® process creates a bio-inductive scaffold resulting from to the removal of DNA and cellular material from biological tissues, DermaPure enables the patient’s cells to repopulate and colonize, creating new tissue that is recognized and accepted by the body and stimulates a natural healing process.

According to James Lukban, DO, FACOG, FACS, FFPMRS, a Colorado-based urogynecologic surgeon, “Since learning about DermaPure from ARMS Medical, I have been very impressed by its advantages over other technologies and competitive biologics. It offers good handling characteristics, is easy to place, incorporates well into surrounding tissue and has a negligible exposure rate. The proprietary dCELL technology promotes tissue growth and healing more effectively than cross-linked products. and I continue to advocate strongly for its use in pelvic organ prolapse and surgical repair.”